CompletedPhase 4NCT00589628

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Egla C. Rabinovich
Principal Investigator
Egla Rabinovich, MD. MPH
Duke University
Intervention
infliximab(drug)
Enrollment
13 target
Eligibility
4-18 years · All sexes
Timeline
20072010

Study locations (1)

Collaborators

Childhood Arthritis and Rheumatology Research Alliance

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00589628 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials